Jun 13,2024 TOP STORY

Veris Health Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center

PAVmed subsidiary Veris Health has initiated a pilot program in collaboration with The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute. The program marks the first enrollment of patients on the Veris Cancer Care Platform, designed for personalized cancer care through remote patient monitoring using biologic sensors and connected devices. This platform integrates physiological data collection, symptom reporting, telehealth capabilities, and electronic health record integration. It aims to enhance cancer care by detecting complications early, reducing unplanned hospitalizations, providing longitudinal data trends, and offering data-driven risk management tools.

COLLABORATION PARTNERSHIP

#institution

#rpm

#connected device

View Analyst & Ambassador Comments
Go to original news
Jun 19,2024 TOP STORY

Mika Health, AstraZeneca, and Daiichi Sankyo Partner on UNITE Program

Mika Health has partnered with AstraZeneca and Daiichi Sankyo on the "UNITE" program to enhance support for breast cancer patients in Switzerland. Mika Health, known for its digital therapeutic platform aiding over 100,000 cancer patients, will provide mental health coaching, AI-powered recommendations, and symptom monitoring through its app. The UNITE program, starting in German-speaking regions and expanding to French and Italian-speaking areas, integrates these digital solutions with prescribed medications. The Mika Health app, combining therapeutic methods and AI, offers educational content and support for depressive symptoms and fatigue.

COLLABORATION PARTNERSHIP

#institution

#coaching

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jun 06,2024 TOP STORY

CureApp and Teijin Pharma Sign Agreement for Joint Marketing and Sales of Prescription Digital Therapeutic App for Hypertension

Teijin Pharma and CureApp have signed a joint agreement to market and sell CureApp HT, a prescription digital therapeutic app for hypertension, starting April 1st. CureApp HT, approved in Japan, supports lifestyle modifications essential for hypertension treatment. The partnership aims to expand CureApp HT’s use by leveraging Teijin Pharma's expertise in lifestyle-related medical devices and CureApp's digital therapeutics knowledge. This collaboration intends to improve patient adherence to lifestyle changes and overall management of hypertension, contributing to better patient outcomes and quality of life.

COLLABORATION PARTNERSHIP

#institution

#pdt

View Analyst & Ambassador Comments
Go to original news
Jun 03,2024

Massive Bio and Un Ensayo Para Mi Partner to Transform Oncology Clinical Trial Access and Deploy AI Technologies Across LATAM

Massive Bio and Un Ensayo Para Mi have joined forces to expand access to oncology clinical trials across nine LATAM countries. Leveraging Massive Bio's AI-driven technology and UEPM's extensive network, the partnership aims to streamline the clinical trial enrollment process and improve patient care in Latin America. By integrating Massive Bio's solutions, UEPM will enhance the accuracy and efficiency of clinical trial matching, ultimately advancing cancer research and treatment outcomes in the region.

COLLABORATION PARTNERSHIP

#institution

#ai/software

View Analyst & Ambassador Comments
Go to original news
Dec 07,2022

MINDMAZE AND VIBRA HEALTHCARE PARTNER TO DELIVER ADVANCED DIGITAL MEDICINE AND NEUROREHABILITATION SOLUTIONS FOR PATIENTS FROM CLINIC-TO-HOME

MindMaze and Vibra Healthcare are partnering to deploy MindMaze's digital health technology platform, including MindPod® and MindMotion®GO, in select Vibra hospitals in Kentucky and California. The platform aims to help patients regain function through digitally-enabled assessments and behavioral training for various neurological conditions like Stroke, TBI, Parkinson's Disease, and more. This collaboration will enable clinicians to deliver interventions with higher dosage and intensity levels, enhancing patient care across different healthcare settings.

COLLABORATION PARTNERSHIP

#institution

#virtual reality

View Analyst & Ambassador Comments
Go to original news
May 30,2024

Leeds teaching hospitals introduces new smartphone app to aid parkinson’s disease management

Leeds Teaching Hospitals Trust Innovation Team has collaborated with Neu Health to introduce a smartphone application aimed at monitoring and managing Parkinson’s disease symptoms in a new pilot program. The app, tailored to the unique needs of Parkinson’s patients, integrates seamlessly with clinical care teams, providing valuable insights to healthcare professionals. Users can easily log symptoms, access digital tests, and receive personalized health information. Currently benefiting up to 90 patients at Leeds Teaching Hospitals, the app aims for further expansion in the future.

COLLABORATION PARTNERSHIP

#institution

#mobile app

View Analyst & Ambassador Comments
Go to original news
Sep 30,2021

Cytoreason and Summit Pharmaceuticals International forge commercial alliance to bring CytoReason’s machine learning model of the immune system for drug discovery & development to Japanese drug makers

CytoReason and Summit Pharmaceuticals International Corporation (SPI) have formed a commercial partnership to introduce CytoReason’s immune-focused machine learning platform to the Japanese pharmaceutical market. The alliance aims to utilize SPI’s expertise and network to showcase CytoReason’s capabilities in disease understanding, biomarker discovery, adverse event profiling, and indication selection. With undisclosed financial terms, CytoReason, known for its collaborations with major pharmaceutical companies, sees Japan as a crucial market for improving drug discovery and development. SPI, a subsidiary of Sumitomo Corporation, views this collaboration as essential for driving innovation in drug research and enhancing the success rate of R&D programs in Japan's pharmaceutical industry.

COLLABORATION PARTNERSHIP

#institution

#ai/software

#ml

View Analyst & Ambassador Comments
Go to original news
Feb 15,2024

Biofourmis and WellSpan Health Collaborate to Deliver High-Quality Hospital-Level Acute and Post-Discharge Care to Patients at Home

Biofourmis and WellSpan Health are collaborating to enhance hospital-level acute and post-discharge care at home for patients. WellSpan, an advanced health system with eight hospitals, will use Biofourmis’s remote patient management platform to replace its current system. This platform integrates with WellSpan’s Epic EMR system, providing continuous patient monitoring, clinical insights, and automated care prompts. The partnership aims to manage over 400 patients monthly, reduce hospital readmission rates, and expand hospital-at-home patient volumes by 75% in three years.

COLLABORATION PARTNERSHIP

#institution

#rpm

View Analyst & Ambassador Comments
Go to original news
May 09,2024 TOP STORY

Evolent and Careology form strategic care navigation partnership to enhance cancer care in the U.S.

Evolent Health, Inc. has partnered with Careology, a digital cancer care platform, to enhance cancer care experiences for patients in the U.S. This collaboration integrates Careology's patient-focused digital solution with Evolent's care navigation services, aiming to provide personalized and connected support for cancer patients. The platform will empower patients to understand their diagnoses, manage treatments, and monitor symptoms effectively. By leveraging data-driven insights, the partnership aims to identify patients who would benefit from personalized navigation services, potentially reducing emergency visits and costs associated with cancer care. The integrated platform is set to launch by the end of 2024, with a national rollout planned for 2025. As part of the collaboration, Evolent's president, Dan McCarthy, will join the Careology board.

COLLABORATION PARTNERSHIP

#institution

#platform

View Analyst & Ambassador Comments
Go to original news
May 09,2024

Blackford and Thirona Enter into a Commercial Partnership

Blackford and Thirona have announced a commercial partnership to make the LungQTM solution available to healthcare professionals through the Blackford Platform. Blackford offers access to over 130 AI solutions designed to enhance clinical accuracy and efficiency, while Thirona specializes in AI-based lung image analysis. By integrating Thirona's technology into the Blackford Platform, healthcare providers can access powerful tools for analyzing thoracic CT scans to improve the treatment of pulmonary diseases. The LungQTM clinical software supports diagnosis and treatment planning for conditions like COPD, enabling quantitative measurements and personalized treatment approaches. This collaboration aims to support clinicians in providing the best possible patient care by delivering innovative AI tools for lung disease assessments.

COLLABORATION PARTNERSHIP

#institution

#ai/software

#clinical decision support

View Analyst & Ambassador Comments
Go to original news
Subscribe to INSTITUTION